ELIXIRGEN THERAPEUTICS Trademark

Trademark Overview


On Wednesday, December 1, 2021, a trademark application was filed for ELIXIRGEN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELIXIRGEN THERAPEUTICS trademark a serial number of 97976453. The federal status of this trademark filing is REGISTERED as of Tuesday, December 12, 2023. This trademark is owned by Elixirgen Therapeutics, Inc.. The ELIXIRGEN THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical drugs for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for medicinal purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; preparations of organisms for medical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases

Research and development of vaccines and medicines; testing of pharmaceuticals; research in the field of pharmaceuticals
elixirgen therapeutics

General Information


Serial Number97976453
Word MarkELIXIRGEN THERAPEUTICS
Filing DateWednesday, December 1, 2021
Status700 - REGISTERED
Status DateTuesday, December 12, 2023
Registration Number7244784
Registration DateTuesday, December 12, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical drugs for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for medicinal purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases; preparations of organisms for medical purposes, namely, for the treatment of infectious diseases, cancer, and aging-related diseases
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development of vaccines and medicines; testing of pharmaceuticals; research in the field of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code005
First Use Anywhere DateThursday, July 6, 2023
First Use In Commerce DateThursday, July 6, 2023

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 6, 2021
Primary Code042
First Use Anywhere DateSaturday, October 15, 2022
First Use In Commerce DateSaturday, October 15, 2022

Trademark Owner History


Party NameElixirgen Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Party NameElixirgen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Party NameElixirgen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Trademark Events


Event DateEvent Description
Tuesday, December 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 7, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, November 6, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 12, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 22, 2023USE AMENDMENT FILED
Tuesday, September 12, 2023SOU EXTENSION 1 GRANTED
Tuesday, August 22, 2023SOU EXTENSION 1 FILED
Tuesday, September 12, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, August 22, 2023DIVISIONAL REQUEST RECEIVED
Monday, August 28, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 22, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 22, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, August 22, 2023TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 19, 2022NON-FINAL ACTION E-MAILED
Monday, September 19, 2022NON-FINAL ACTION WRITTEN
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 4, 2021NEW APPLICATION ENTERED